4 ms·
> It's because Chinese define democracy by whether they believe their government works for their interest and whether they yield good results, not by how their
by mschuster91 4y ago
> It's because Chinese define democracy by whether they believe their government works for their interest and whether they yield good results, not by how their government is elected.
And here is the crux of China's zero-covid policy. Follow the Western lead and run covid run its course? That would be millions of deaths even with Omicron being not as deadly, simply because Sinovax is nowhere near as effective as the mRNA vaccines are. It's too late (and politically unwise, given how CCP propaganda praised its selfmade vaccine) to mass-rollout mRNA vaccines, so the only option that prevents millions of deaths (and so, keeps the "social contract" of freedoms vs. wealth) is to brutally suppress Covid.
The interesting thing will be when the Chinese public deems the zero-covid policy "not good enough"...
- FooBarWidget 4y agoActually, Sinovac work as well as Pfizer when it comes to preventing hospitilization and death, but requires sufficient boosters. This is shown by this research paper: https://www.medrxiv.org/content/10.1101/2022.03.22.22272769v2 https://www.medrxiv.org/content/10.1101/2022.03.22.22272769v... The "Chinese vaccine don't work" talking point is a bad faith myth created by western mainstream media, which misrepresented this study by comparing single- or two-dose Sinovac with 3-dose Pfizer. This sort of misrepresentation is unfortunately common practice in mainstream western media. What is true however is that Chinese population has less immunity against omicron due to lower vaccination rates, especially among the elderly. For one, the Chinese don't see vaccination as really necessary because lockdowns work. Second, the Chinese worry a lot more about vaccine side effects. Here in the Netherlands, vaccines are sold as "100% safe, everyone should get it", whereas in China doctors would recommend against getting a vaccine if you have another medical problem such as heart problems. My other grandparents in law choose not to get vaccinated because they have many other health problems due to old age. Finally, the Chinese public is by and large very supportive of lockdowns despite the Shanghai mess. Rather than "don't lock down" they now just believe "lock down earlier, don't turn into the next Shanghai".
- oivey 4y ago> The "Chinese vaccine don't work" talking point is a bad faith myth created by western mainstream media, which misrepresented this study by comparing single- or two-dose Sinovac with 3-dose Pfizer. This sort of misrepresentation is unfortunately common practice in mainstream western media. This isn’t true, and if you look at table 2 in the paper you link it is obvious. With equal dosing, SinoVac is less effective than Pfizer in basically all categories. SinoVac doesn’t start to have _any_ protection against mild/moderate disease until 3 doses, and even then, it’s significantly worse than Pfizer. It’s hard to know how that relates to disease transmission, but it’s probably fair to guess that less protection against mild/moderate disease means increased viral loads and faster disease spread.
- FooBarWidget 4y agoYes with equal dose before the third dose it's less effective, but why would one compare the two vaccines based on number of dosis to get effective? Back when there were fewer variants, the Janssen vaccine only required 1 dose; was Janssen "better" than mRNA, and did "mRNA vaccines not work very well"? Here in the Netherlands, once Omikron arrived, the Dutch CDC advised everyone to get a booster (third dose). Nobody here counts on Pfizer having enough protection with just 2 doses. Why would anyone then compare 2-dose Pfizer with 2-dose Sinovac? What matters is the eventual efficacy after sufficient boosters. Besides, we already live in a "booster subscription" reality. Here in the Netherlands, the elderly are encouraged to get a booster every 3 or 4 months. In light of all this, I'd say it's very disingenuous to compare based on number of dosis instead of eventual efficacy. And you say "even [after 3 doses] it's significantly worse than Pfizer". Where in table 2 do you see that? Severe/fatal disease: - Three-dose BNT162B2: 99.2 for 60-69 yr, 99.5 for 70-79 yr, 95.7 for >= 80 yr - Three-dose Coronavac: 98.5 for 60-69 yr, 96.7 for 70-79 yr, 98.6 for >= 80 yr Mortality: - Three-dose BNT162B2: 98.9 for 60-69 yr, 96.0 for >= 80 yr - Three-dose Coronavac: 98.7 for 60-69 yr, 99.2 for >= 80 yr I'm sorry, these numbers look nearly identical to me? They're all >= 96% for the elderly. I think you're looking at the "mild/moderate" section. Yes the numbers there are lower for Sinovac. But so what? Protection against severe/fatal disease and mortality is the most important. That it's less effective at mild/moderate disease prevention doesn't make "Chinese vaccine don't work very well". Heck if we go back in time before there were so many variants, various studies showed Sinovac as having roughly 70% protection against mild/moderate COVID (depending on country; efficacy is context-dependent). That 70% was then branded by western media as "Chinese vaccines are junk, they don't work at all, because our mRNA vaccines provide 90%+ protection against mild disease". And now Pfizer has only 70% protection against mild omikron but it's still represented as "mRNA vaccines are much superior, the Chinese are fscked until they get their hands on mRNA". Yes, what's wrong with that narrative? For some reason, outside of the context of comparisons with China, everybody agrees that Pfizer works kinda "meh" against omikron; it's merely "good enough to get the job done". But when comparing with China, all sorts of people are suddenly inclined to represent mRNA as the holy grail that can end the pandemic, which the Chinese unfortunately don't have.